Clinical relevance of VEGF receptors 1 and 2 in patients with chronic myelogenous leukemia.

Abstract

Vascularity is increased in the bone marrow of patients with chronic myeloid leukemia (CML) and high vascular endothelial growth factor (VEGF) levels correlate with worse survival. We analyzed the significance of VEGF-receptor 1 (VEGF-R1) and VEGF-R2 levels in bone marrow samples from 170 CML patients (137 chronic, 24 accelerated, and 9 blastic phase… (More)

Topics

Cite this paper

@article{Verstovsek2003ClinicalRO, title={Clinical relevance of VEGF receptors 1 and 2 in patients with chronic myelogenous leukemia.}, author={Srdan Verstovsek and Scott D Lunin and Hagop M. Kantarjian and Taghi Manshouri and Stefan H. Faderl and Jorge Cort{\'e}s and Francis Joseph Giles and Maher Albitar}, journal={Leukemia research}, year={2003}, volume={27 7}, pages={661-9} }